Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fiala

Showing results (131-140 of 167) with videos related to

Pageof 17
Sort By:
Cancer Medicine|November 21, 2022
Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to raceJennifer Berrian, Ying Liu, Nkiruka Ezenwajiaku, et al.
Blood Advances|September 23, 2021
Machine learning-based scoring models to predict hematopoietic stem cell mobilization in allogeneic donorsJingyu Xiang, Min Shi, Mark A Fiala, et al.
Bone Marrow Transplantation|July 29, 2014
A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myelomaT-F Wang, M A Fiala, A F Cashen, et al.
Nature Communications|February 26, 2015
Erratum: Synthetic retinal analogs modify the spectral and kinetic characteristics of microbial rhodopsin optogenetic toolsN AzimiHashemi, K Erbguth, A Vogt, et al.
Nature Communications|May 31, 2020
Evolution and structure of clinically relevant gene fusions in multiple myelomaSteven M Foltz, Qingsong Gao, Christopher J Yoon, et al.
Nature Communications|December 16, 2014
Synthetic retinal analogues modify the spectral and kinetic characteristics of microbial rhodopsin optogenetic toolsN AzimiHashemi, K Erbguth, A Vogt, et al.
Leukemia & Lymphoma|December 18, 2015
A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemiaLukas D Wartman, Mark A Fiala, Theresa Fletcher, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|June 3, 2020
Knowledge, attitude and practice towards abortion and post abortion care among Egyptian private obstetricians and gynaecologistsZakia M Ibrahim, Mariam L Mohamed, Omima T Taha, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin LymphomaPavan Kumar Bhamidipati, Mark A Fiala, Brenda J Grossman, et al.
Patient Preference and Adherence|March 8, 2022
Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United StatesDaniel Auclair, Carol Mansfield, Mark A Fiala, et al.
Pageof 17

Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Cancer Medicine|November 21, 2022
Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to raceJennifer Berrian, Ying Liu, Nkiruka Ezenwajiaku, et al.
Blood Advances|September 23, 2021
Machine learning-based scoring models to predict hematopoietic stem cell mobilization in allogeneic donorsJingyu Xiang, Min Shi, Mark A Fiala, et al.
Bone Marrow Transplantation|July 29, 2014
A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myelomaT-F Wang, M A Fiala, A F Cashen, et al.
Nature Communications|February 26, 2015
Erratum: Synthetic retinal analogs modify the spectral and kinetic characteristics of microbial rhodopsin optogenetic toolsN AzimiHashemi, K Erbguth, A Vogt, et al.
Nature Communications|May 31, 2020
Evolution and structure of clinically relevant gene fusions in multiple myelomaSteven M Foltz, Qingsong Gao, Christopher J Yoon, et al.
Nature Communications|December 16, 2014
Synthetic retinal analogues modify the spectral and kinetic characteristics of microbial rhodopsin optogenetic toolsN AzimiHashemi, K Erbguth, A Vogt, et al.
Leukemia & Lymphoma|December 18, 2015
A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemiaLukas D Wartman, Mark A Fiala, Theresa Fletcher, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|June 3, 2020
Knowledge, attitude and practice towards abortion and post abortion care among Egyptian private obstetricians and gynaecologistsZakia M Ibrahim, Mariam L Mohamed, Omima T Taha, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin LymphomaPavan Kumar Bhamidipati, Mark A Fiala, Brenda J Grossman, et al.
Patient Preference and Adherence|March 8, 2022
Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United StatesDaniel Auclair, Carol Mansfield, Mark A Fiala, et al.
Pageof 17